• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PFIZER CONSUMER HEALTH CARE THERMACARE MENSTRUAL; DISPOSABLE PACK, HOT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PFIZER CONSUMER HEALTH CARE THERMACARE MENSTRUAL; DISPOSABLE PACK, HOT Back to Search Results
Lot Number J23219
Device Problems Leak/Splash (1354); Structural Problem (2506)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
Our manufacturing operations employ quality control procedures which include in-process testing, thermal testing and visual inspection, to ensure the quality of the product being packaged.No quality issues were identified upon this review of the batch device history record, in process attributes and variable quality checks or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.The consumer returned sample shows the wraps had cells that were cut by the final knife allowing chemistry to leak out side of the wrap.A previous investigation was completed for this batch with confirmed cells cut and chemistry leaking to outside of wrap.The investigation determined the most probable root cause of this defect is classified as method/document does not exist.There is no manufacturing working instruction (mwi) that explains how to perform die-cutter re-adjustments during production.In addition, no procedure was identified that contains the instruction to open the cull station during the die-cutter re-adjustments to ensure all produced wraps are rejected and do not move to the packaging portion of the manufacturing line.During production of batch j23219 two different shifts noted die cutter openings due to issues keeping die phasing in time with the wraps.The electrical and instrumentation (e&i) technicians had to re-phase the die in order to prevent cutting cells.When re-phasing the die, the technician should open the cull station manually to ensure no defective wraps are allowed to transition to packaging.This phasing outage can develop during normal production operations due to web movement while transitioning through the manufacturing line.Preventative action was issued to create a manufacturing work instruction for die cutter calibration.
 
Event Description
Event verbatim [preferred term] heat wrap is cut wrong, so the granulate leaks out [device leakage].Case narrative: this is a spontaneous report from a contactable pharmacist.A patient of unspecified age and gender started to use thermacare heatwrap (thermacare menstrual) (device lot number j23219, expiration date aug2017) from an unspecified date for an unspecified indication.The patient's medical history and concomitant medications were not reported.On an unspecified date, the patient reported the heatwrap is cut wrong, so the granulate leaks out.Action taken with the suspect product was unknown.Clinical outcome of the event was unknown.Additional information received from product quality complaint (pqc) group included investigation results.Our manufacturing operations employ quality control procedures which include in-process testing, thermal testing and visual inspection, to ensure the quality of the product being packaged.No quality issues were identified upon this review of the batch device history record, in process attributes and variable quality checks or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.The consumer returned sample shows the wraps had cells that were cut by the final knife allowing chemistry to leak out side of the wrap.A previous investigation was completed for this batch with confirmed cells cut and chemistry leaking to outside of wrap.The investigation determined the most probable root cause of this defect is classified as method/document does not exist.There is no manufacturing working instruction (mwi) that explains how to perform die-cutter re-adjustments during production.In addition, no procedure was identified that contains the instruction to open the cull station during the die-cutter re-adjustments to ensure all produced wraps are rejected and do not move to the packaging portion of the manufacturing line.During production of batch j23219 two different shifts noted die cutter openings due to issues keeping die phasing in time with the wraps.The electrical and instrumentation (e&i) technicians had to re-phase the die in order to prevent cutting cells.When re-phasing the die, the technician should open the cull station manually to ensure no defective wraps are allowed to transition to packaging.This phasing outage can develop during normal production operations due to web movement while transitioning through the manufacturing line.Preventative action was issued to create a manufacturing work instruction for die cutter calibration.Follow-up (23feb2017): new information received from product quality complaints (pqc) group included: product quality investigation results.No follow-up attempts are needed/possible.No further information is expected.Company clinical evaluation comment the event "heatwrap is cut wrong, so the granulate leaks out" (device leakage) was assessed as non-serious.No other adverse event was associated with the use of the device.This is a single potential device malfunction has a theoretical risk to cause skin burn.The event was assessed as associated with the use of the device., comment: the event "heatwrap is cut wrong, so the granulate leaks out" (device leakage) was assessed as non-serious.No other adverse event was associated with the use of the device.This is a single potential device malfunction has a theoretical risk to cause skin burn.The event was assessed as associated with the use of the device.
 
Event Description
Event verbatim [preferred term] heat wrap is cut wrong, so the granulate leaks out [device leakage].Case narrative:this is a spontaneous report from a contactable pharmacist.A patient of unspecified age and gender started to use thermacare heatwrap (thermacare menstrual) (device lot number j23219, expiration date aug2017) from an unspecified date for an unspecified indication.The patient's medical history and concomitant medications were not reported.On an unspecified date, the patient experienced the heatwrap was cut wrong, so the granulate leaks out.Action taken with the suspect product was unknown.Clinical outcome of the event was unknown.Additional information received from product quality complaint (pqc) group included investigation results.Our manufacturing operations employ quality control procedures which include in-process testing, thermal testing and visual inspection, to ensure the quality of the product being packaged.No quality issues were identified upon this review of the batch device history record, in process attributes and variable quality checks or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.The consumer returned sample shows the wraps had cells that were cut by the final knife allowing chemistry to leak out side of the wrap.A previous investigation was completed for this batch with confirmed cells cut and chemistry leaking to outside of wrap.The investigation determined the most probable root cause of this defect is classified as method/document does not exist.There is no manufacturing working instruction (mwi) that explains how to perform die-cutter re-adjustments during production.In addition, no procedure was identified that contains the instruction to open the cull station during the die-cutter re-adjustments to ensure all produced wraps are rejected and do not move to the packaging portion of the manufacturing line.During production of batch j23219 two different shifts noted die cutter openings due to issues keeping die phasing in time with the wraps.The electrical and instrumentation (e&i) technicians had to re-phase the die in order to prevent cutting cells.When re-phasing the die, the technician should open the cull station manually to ensure no defective wraps are allowed to transition to packaging.This phasing outage can develop during normal production operations due to web movement while transitioning through the manufacturing line.Preventative action was issued to create a manufacturing work instruction for die cutter calibration.Follow-up (23feb2017): new information received from product quality complaints (pqc) group included: product quality investigation results.No follow-up attempts are needed/possible.No further information is expected.Follow-up (16dec2019): this follow-up report is being submitted as a final reportable mdr., comment: the event "heatwrap is cut wrong, so the granulate leaks out" (device leakage) was assessed as non-serious.No other adverse event was associated with the use of the device.This is a single potential device malfunction has a theoretical risk to cause skin burn.The event was assessed as associated with the use of the device.Company conducted an investigation, and the most probable root cause for this event was classified, capa was implemented, and no further action is recommended.
 
Manufacturer Narrative
Our manufacturing operations employ quality control procedures which include in-process testing, thermal testing and visual inspection, to ensure the quality of the product being packaged.No quality issues were identified upon this review of the batch device history record, in process attributes and variable quality checks or, inspection of retained samples.Retained samples met the product description and the product is within expiration date.The consumer returned sample shows the wraps had cells that were cut by the final knife allowing chemistry to leak out side of the wrap.A previous investigation was completed for this batch with confirmed cells cut and chemistry leaking to outside of wrap.The investigation determined the most probable root cause of this defect is classified as method/document does not exist.There is no manufacturing working instruction (mwi) that explains how to perform die-cutter re-adjustments during production.In addition, no procedure was identified that contains the instruction to open the cull station during the die-cutter re-adjustments to ensure all produced wraps are rejected and do not move to the packaging portion of the manufacturing line.During production of batch j23219 two different shifts noted die cutter openings due to issues keeping die phasing in time with the wraps.The electrical and instrumentation (e&i) technicians had to re-phase the die in order to prevent cutting cells.When re-phasing the die, the technician should open the cull station manually to ensure no defective wraps are allowed to transition to packaging.This phasing outage can develop during normal production operations due to web movement while transitioning through the manufacturing line.Preventative action was issued to create a manufacturing work instruction for die cutter calibration.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMACARE MENSTRUAL
Type of Device
DISPOSABLE PACK, HOT
Manufacturer (Section D)
PFIZER CONSUMER HEALTH CARE
1231 wyandotte drive
albany GA 31705
MDR Report Key9263328
MDR Text Key219955650
Report Number1066015-2019-00451
Device Sequence Number1
Product Code IMD
Combination Product (y/n)N
PMA/PMN Number
K953442
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date08/01/2017
Device Lot NumberJ23219
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/31/2019
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-